MODULE 1: BASIC PRINCIPLES OF
PHARMACOLOGY & COMFORT
MEDICATION
ACTIVITY 1
NSG124.01.01.01 BASIC APPLICATION OF NURSING PHARMACOLOGY
PREADMINISTRATION ASSESSMENT
Collection of baseline data to evaluate therapeutic and adverse responses, identify high-risk
patients, and assess the patient's capacity for self-care.
Previous
Play
Next
Rewind 10 seconds
Move forward 10 seconds
Unmute
0:00
/
0:15
Full screen
Brainpower
Read More
MINIMIZING ADVERSE EFFECTS
Implementation of nursing measures to decrease undesired effects of drugs.
DOSAGE AND ADMINISTRATION
Knowledge and application of the five rights of drug administration: giving the right drug to the
right patient, in the right dose by the right route at the right time.
MINIMIZING ADVERSE INTERACTIONS
,Complete a thorough drug history, educate patients to avoid OTC drugs, and monitoring for
possible drug interactions.
PROMOTION OF THERAPEUTIC EFFECTS
Enhancement of therapeutic effects by nonpharmacological, supportive, or coordination
measures.
MAKING PRN DECISIONS
Implementation of as needed orders with logic. Knowledge of reason for drug and ability to
assess the patient's medication needs.
MANAGING TOXICITY
Proficiently montior patients and respond to early signs of dangerous adverse drug reactions.
Pharmacokinetic processes determine how much of an administered drug dose gets to the site
of action. Which of the following are pharmacokinetic processes? Select all that apply.
Drug dosing schedule
Drug metabolism
Drug excretion
Drug absorption
Drug metabolism
Drug excretion
Drug absorption
Drug distribution
ACTIVITY 2
NSG124.01.01.02 DRUG REGULATION, DEVELOPMENT, AND NAMING
CHEMICAL NAME
Constitutes a description of a drug using the nomenclature of chemistry
BRAND NAME
Known as the proprietary or trade name. Created to be easy for nurses, doctors, physicians,
pharamacists, and consumers to recall and pronounce.
, GENERIC NAME
Known as the nonproprietary name. This name usually indicates a drug's pharmacological
class.
COMPREHENSIVE ADDICTION AND RECOVERY ACT OF 2016
Law to combat the nationwide opioid epidemic utilizing multiple approaches.
FEDERAL PURE FOOD AND DRUG ACT
First American law to regulate drugs through drug quality and strength standards.
FAMILY SMOKING PREVENTION AND TABACO CONTROL ACT
Passed in 2009, to regulate cigarettes and FDA authority reference nicotine marketing.
HARRIS-KEFAUVER AMENDMENTS
Food, Drug, and Cosmetic Act from 1962 sought to strengthen all aspects of drug regulation,
including efficacy of drug.
CONTROLLED SUBSTANCES ACT
1970 act to enact rules for manufacture and distribution of drugs with abuse potential.
FDA AMENDMENTS ACT
2007 legislation to increase drug safety and oversight.
T/F: Clinical drug development trials occur in 10 phases and may take 10 years to complete.
False.
Clinical drug development trials occur in four phases and may take 2 to 10 years to complete.
Phase I includes healthy volunteers, Phase II and III includes drug tests with patients, Phase IV
includes drug release for general use and post marketing surveillance.
ACTIVITY 3
NSG124.01.01.03 OTC, PRESCRIPTION DRUGS, AND INFORMATION SOURCES
PHARMACOLOGY & COMFORT
MEDICATION
ACTIVITY 1
NSG124.01.01.01 BASIC APPLICATION OF NURSING PHARMACOLOGY
PREADMINISTRATION ASSESSMENT
Collection of baseline data to evaluate therapeutic and adverse responses, identify high-risk
patients, and assess the patient's capacity for self-care.
Previous
Play
Next
Rewind 10 seconds
Move forward 10 seconds
Unmute
0:00
/
0:15
Full screen
Brainpower
Read More
MINIMIZING ADVERSE EFFECTS
Implementation of nursing measures to decrease undesired effects of drugs.
DOSAGE AND ADMINISTRATION
Knowledge and application of the five rights of drug administration: giving the right drug to the
right patient, in the right dose by the right route at the right time.
MINIMIZING ADVERSE INTERACTIONS
,Complete a thorough drug history, educate patients to avoid OTC drugs, and monitoring for
possible drug interactions.
PROMOTION OF THERAPEUTIC EFFECTS
Enhancement of therapeutic effects by nonpharmacological, supportive, or coordination
measures.
MAKING PRN DECISIONS
Implementation of as needed orders with logic. Knowledge of reason for drug and ability to
assess the patient's medication needs.
MANAGING TOXICITY
Proficiently montior patients and respond to early signs of dangerous adverse drug reactions.
Pharmacokinetic processes determine how much of an administered drug dose gets to the site
of action. Which of the following are pharmacokinetic processes? Select all that apply.
Drug dosing schedule
Drug metabolism
Drug excretion
Drug absorption
Drug metabolism
Drug excretion
Drug absorption
Drug distribution
ACTIVITY 2
NSG124.01.01.02 DRUG REGULATION, DEVELOPMENT, AND NAMING
CHEMICAL NAME
Constitutes a description of a drug using the nomenclature of chemistry
BRAND NAME
Known as the proprietary or trade name. Created to be easy for nurses, doctors, physicians,
pharamacists, and consumers to recall and pronounce.
, GENERIC NAME
Known as the nonproprietary name. This name usually indicates a drug's pharmacological
class.
COMPREHENSIVE ADDICTION AND RECOVERY ACT OF 2016
Law to combat the nationwide opioid epidemic utilizing multiple approaches.
FEDERAL PURE FOOD AND DRUG ACT
First American law to regulate drugs through drug quality and strength standards.
FAMILY SMOKING PREVENTION AND TABACO CONTROL ACT
Passed in 2009, to regulate cigarettes and FDA authority reference nicotine marketing.
HARRIS-KEFAUVER AMENDMENTS
Food, Drug, and Cosmetic Act from 1962 sought to strengthen all aspects of drug regulation,
including efficacy of drug.
CONTROLLED SUBSTANCES ACT
1970 act to enact rules for manufacture and distribution of drugs with abuse potential.
FDA AMENDMENTS ACT
2007 legislation to increase drug safety and oversight.
T/F: Clinical drug development trials occur in 10 phases and may take 10 years to complete.
False.
Clinical drug development trials occur in four phases and may take 2 to 10 years to complete.
Phase I includes healthy volunteers, Phase II and III includes drug tests with patients, Phase IV
includes drug release for general use and post marketing surveillance.
ACTIVITY 3
NSG124.01.01.03 OTC, PRESCRIPTION DRUGS, AND INFORMATION SOURCES
